
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5159425
[patent_doc_number] => 20070172469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Methods For Inhibiting Viral Replication In Vivo'
[patent_app_type] => utility
[patent_app_number] => 11/689166
[patent_app_country] => US
[patent_app_date] => 2007-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17951
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172469.pdf
[firstpage_image] =>[orig_patent_app_number] => 11689166
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/689166 | Methods For Inhibiting Viral Replication In Vivo | Mar 20, 2007 | Abandoned |
Array
(
[id] => 4567369
[patent_doc_number] => 07858335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Microorganisms and assays for the identification of antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/709370
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17627
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709370
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709370 | Microorganisms and assays for the identification of antibiotics | Feb 21, 2007 | Issued |
Array
(
[id] => 5015783
[patent_doc_number] => 20070258991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'IMMUNOGENIC AGENT THERAPY USING PLASMAPHERESIS'
[patent_app_type] => utility
[patent_app_number] => 11/677853
[patent_app_country] => US
[patent_app_date] => 2007-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3286
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20070258991.pdf
[firstpage_image] =>[orig_patent_app_number] => 11677853
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/677853 | IMMUNOGENIC AGENT THERAPY USING PLASMAPHERESIS | Feb 21, 2007 | Abandoned |
Array
(
[id] => 826652
[patent_doc_number] => 07402315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-22
[patent_title] => 'Hepatitis-C virus type 4, 5 and 6'
[patent_app_type] => utility
[patent_app_number] => 11/676842
[patent_app_country] => US
[patent_app_date] => 2007-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12099
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/402/07402315.pdf
[firstpage_image] =>[orig_patent_app_number] => 11676842
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/676842 | Hepatitis-C virus type 4, 5 and 6 | Feb 19, 2007 | Issued |
Array
(
[id] => 5022718
[patent_doc_number] => 20070148684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'IMMUNOASSAY FOR HIV PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 11/673031
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5626
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11673031
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/673031 | IMMUNOASSAY FOR HIV PROTEASE INHIBITORS | Feb 8, 2007 | Abandoned |
Array
(
[id] => 5022723
[patent_doc_number] => 20070148689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases'
[patent_app_type] => utility
[patent_app_number] => 11/703796
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20342
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11703796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/703796 | Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases | Feb 7, 2007 | Abandoned |
Array
(
[id] => 5225085
[patent_doc_number] => 20070254351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Method for the preparation of purified HCV RNA by exosome separation'
[patent_app_type] => utility
[patent_app_number] => 11/699925
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2788
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254351.pdf
[firstpage_image] =>[orig_patent_app_number] => 11699925
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/699925 | Preparation of purified exosomes comprising HCV RNA | Jan 29, 2007 | Issued |
Array
(
[id] => 4921516
[patent_doc_number] => 20080069831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'YEAST-BASED THERAPEUTIC FOR CHRONIC HEPATITIS C INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/618833
[patent_app_country] => US
[patent_app_date] => 2006-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32683
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20080069831.pdf
[firstpage_image] =>[orig_patent_app_number] => 11618833
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/618833 | Yeast-based therapeutic for chronic hepatitis C infection | Dec 30, 2006 | Issued |
Array
(
[id] => 202029
[patent_doc_number] => 07632511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Yeast-based therapeutic for chronic hepatitis C infection'
[patent_app_type] => utility
[patent_app_number] => 11/618834
[patent_app_country] => US
[patent_app_date] => 2006-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 50
[patent_no_of_words] => 32764
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632511.pdf
[firstpage_image] =>[orig_patent_app_number] => 11618834
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/618834 | Yeast-based therapeutic for chronic hepatitis C infection | Dec 30, 2006 | Issued |
Array
(
[id] => 5130770
[patent_doc_number] => 20070207167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Immunologically enhanced recombinant vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/645817
[patent_app_country] => US
[patent_app_date] => 2006-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13272
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207167.pdf
[firstpage_image] =>[orig_patent_app_number] => 11645817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/645817 | Immunologically enhanced recombinant vaccines | Dec 25, 2006 | Abandoned |
Array
(
[id] => 5022672
[patent_doc_number] => 20070148638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Method for Detecting Low Concentrations of a Target Bacterium That Uses Phages to Infect Target Bacterial Cells'
[patent_app_type] => utility
[patent_app_number] => 11/612587
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6053
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148638.pdf
[firstpage_image] =>[orig_patent_app_number] => 11612587
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612587 | Method for Detecting Low Concentrations of a Target Bacterium That Uses Phages to Infect Target Bacterial Cells | Dec 18, 2006 | Abandoned |
Array
(
[id] => 798082
[patent_doc_number] => 07427669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-23
[patent_title] => 'ULBP antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/638966
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 27874
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/427/07427669.pdf
[firstpage_image] =>[orig_patent_app_number] => 11638966
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/638966 | ULBP antibodies | Dec 12, 2006 | Issued |
Array
(
[id] => 4572125
[patent_doc_number] => 07858752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Recombinant antibodies against hepatitis C virus and methods of obtaining and using same'
[patent_app_type] => utility
[patent_app_number] => 11/633810
[patent_app_country] => US
[patent_app_date] => 2006-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 27848
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11633810
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/633810 | Recombinant antibodies against hepatitis C virus and methods of obtaining and using same | Dec 4, 2006 | Issued |
Array
(
[id] => 5057618
[patent_doc_number] => 20070060540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences'
[patent_app_type] => utility
[patent_app_number] => 11/595552
[patent_app_country] => US
[patent_app_date] => 2006-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15049
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595552
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595552 | Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences | Nov 9, 2006 | Abandoned |
Array
(
[id] => 5253239
[patent_doc_number] => 20070134695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Dengue virus detection measured by immunocytometry in a dendritic cell surrogate'
[patent_app_type] => utility
[patent_app_number] => 11/586895
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3387
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11586895
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/586895 | Dengue virus detection measured by immunocytometry in a dendritic cell surrogate | Oct 25, 2006 | Abandoned |
Array
(
[id] => 5050858
[patent_doc_number] => 20070031403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Interferon-gamma inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/580922
[patent_app_country] => US
[patent_app_date] => 2006-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25382
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031403.pdf
[firstpage_image] =>[orig_patent_app_number] => 11580922
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/580922 | Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use | Oct 15, 2006 | Issued |
Array
(
[id] => 836713
[patent_doc_number] => 07393527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'Method for limiting the growth of cancer cells using an attenuated measles virus'
[patent_app_type] => utility
[patent_app_number] => 11/532879
[patent_app_country] => US
[patent_app_date] => 2006-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9906
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393527.pdf
[firstpage_image] =>[orig_patent_app_number] => 11532879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/532879 | Method for limiting the growth of cancer cells using an attenuated measles virus | Sep 17, 2006 | Issued |
Array
(
[id] => 5565066
[patent_doc_number] => 20090137919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'LUNG VOLUME MONITORING METHOD AND DEVICE'
[patent_app_type] => utility
[patent_app_number] => 12/064963
[patent_app_country] => US
[patent_app_date] => 2006-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4813
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137919.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064963
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064963 | LUNG VOLUME MONITORING METHOD AND DEVICE | Sep 2, 2006 | Abandoned |
Array
(
[id] => 5075224
[patent_doc_number] => 20070015199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Stabilized immunogenic HBc chimer particles'
[patent_app_type] => utility
[patent_app_number] => 11/508655
[patent_app_country] => US
[patent_app_date] => 2006-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 49645
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015199.pdf
[firstpage_image] =>[orig_patent_app_number] => 11508655
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/508655 | Stabilized immunogenic HBc chimer particles | Aug 22, 2006 | Abandoned |
Array
(
[id] => 5148274
[patent_doc_number] => 20070048333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'CD4+ T-lymphocyte-specific Hepatitis C virus-epitopes'
[patent_app_type] => utility
[patent_app_number] => 11/506824
[patent_app_country] => US
[patent_app_date] => 2006-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3573
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11506824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/506824 | CD4+ T-lymphocyte-specific Hepatitis C virus-epitopes | Aug 20, 2006 | Abandoned |